Genaxy Bioinnovations Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 4.60 M
- Company Age 11 Months 12 Days
About Genaxy Bioinnovations
Genaxy Bioinnovations Private Limited (GBPL) is a Private Limited Indian Non-Government Company incorporated in India on 27 February 2024 ( 11 months 12 days old ). Its registered office is in Solan, Himachal Pradesh, India.
The Company is engaged in the Wood Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 4.60 M, as per Ministry of Corporate Affairs (MCA) records.
Navneet Trehan, Mukesh Gupta, Saurabh Gupta, and One other member serve as directors at the Company.
Company Details
-
Location
Solan, Himachal Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U20299HP2024PTC010694
-
Company No.
010694
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
27 Feb 2024
-
Date of AGM
-
-
Date of Balance Sheet
-
-
Listing Status
Unlisted
-
ROC Code
Roc Himachal Pradesh
Industry
Who are the key members and board of directors at Genaxy Bioinnovations?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Saurabh Gupta
|
Director | 27-Feb-2024 | Current |
|
Navneet Trehan
|
Director | 27-Feb-2024 | Current |
|
Mukesh Gupta
|
Director | 27-Feb-2024 | Current |
|
Girish Sehgal
|
Director | 27-Feb-2024 | Current |
Financial Performance of Genaxy Bioinnovations.
Enhance accessibility to Genaxy Bioinnovations's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Genaxy Bioinnovations?
Unlock access to Genaxy Bioinnovations's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Genaxy Scientific Private LimitedNavneet Trehan, Mukesh Gupta and 1 more are mutual person
-
Ayonex Labs Private LimitedGirish Sehgal is a mutual person
-
Future Bio-Science Private LimitedNavneet Trehan and Mukesh Gupta are mutual person
-
Trehan's Appointment With Success Private LimitedNavneet Trehan is a mutual person
-
Bio Genex Surgicals India Pvt Ltd
Mukesh Gupta and Saurabh Gupta are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Genaxy Bioinnovations?
Unlock and access historical data on people associated with Genaxy Bioinnovations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Genaxy Bioinnovations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Genaxy Bioinnovations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.